Methods of treatment using il-17e antagonists
AssigneeAmgen Inc.
InventorsEugene Medlock, Richard Yeh, Scott Michael Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
Life of this patent
Estimating the term…
Abstract
Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
Claims3
A method of treating cystic fibrosis, comprising administering to a patient having cystic fibrosis a composition comprising an antagonistic antibody that specifically binds a protein consisting of SEQ ID NO:2.
A method of treating emphysema, comprising administering to a patient having emphysema a composition comprising an antagonistic antibody that specifically binds a protein consisting of SEQ ID NO:2.
A method of treating acute respiratory distress syndrome, comprising administering to a patient having acute respiratory distress syndrome a composition comprising an antagonistic antibody that specifically binds a protein consisting of SEQ ID NO:2.
Dependencies are inferred from the claim text.